A First-in-class Inhibitor of Hsp110 Molecular Chaperones of Pathogenic Fungi
Overview
Authors
Affiliations
Proteins of the Hsp110 family are molecular chaperones that play important roles in protein homeostasis in eukaryotes. The pathogenic fungus Candida albicans, which causes infections in humans, has a single Hsp110, termed Msi3. Here, we provide proof-of-principle evidence supporting fungal Hsp110s as targets for the development of new antifungal drugs. We identify a pyrazolo[3,4-b] pyridine derivative, termed HLQ2H (or 2H), that inhibits the biochemical and chaperone activities of Msi3, as well as the growth and viability of C. albicans. Moreover, the fungicidal activity of 2H correlates with its inhibition of in vivo protein folding. We propose 2H and related compounds as promising leads for development of new antifungals and as pharmacological tools for the study of the molecular mechanisms and functions of Hsp110s.
Advances in the structures, mechanisms and targeting of molecular chaperones.
Gu J, He Y, He C, Zhang Q, Huang Q, Bai S Signal Transduct Target Ther. 2025; 10(1):84.
PMID: 40069202 PMC: 11897415. DOI: 10.1038/s41392-025-02166-2.
Chaperones vs. oxidative stress in the pathobiology of ischemic stroke.
Soldatov V, Venediktov A, Belykh A, Piavchenko G, Naimzada M, Ogneva N Front Mol Neurosci. 2024; 17:1513084.
PMID: 39723236 PMC: 11668803. DOI: 10.3389/fnmol.2024.1513084.
Characterization of a New Hsp110 Inhibitor as a Potential Antifungal.
Sun C, Li Y, Kidd J, Han J, Ding L, May A J Fungi (Basel). 2024; 10(11).
PMID: 39590652 PMC: 11595998. DOI: 10.3390/jof10110732.
Zhao C, Le X, Li M, Hu Y, Li X, Chen Z Respir Res. 2023; 24(1):289.
PMID: 37978368 PMC: 10655391. DOI: 10.1186/s12931-023-02600-5.